Farcast Biosciences is a diagnostic company focused on facilitating the identification of therapies for cancer patients before they begin treatment and is also optimized to test drug candidates prior to clinical trials. The Farcast platform is ideal for analyzing target engagement, understanding mechanism of action and identifying novel biomarkers. The platform recapitulates the human tumor microenvironment by culturing fresh unmodified human tumor fragments in a proprietary ex vivo histoculture system that includes patient matched immune cells and plasma.

See all Member News